Scale-Up Synthesis of Site-Specific Antibody–Drug Conjugates Using AJICAP Second-Generation Technology
- 6 June 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 27 (6) , 1136-1143
Abstract
No abstract availableKeywords
All Related Versions
This publication has 33 references indexed in Scilit:
- Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody–Drug Conjugates Produced by AJICAP First Generation TechnologyJournal of the American Society for Mass Spectrometry, 2020
- Analytical Comparison of Antibody-drug Conjugates Based on Good Manufacturing Practice StrategiesAnalytical Sciences, 2020
- Antibody–Drug Conjugates Using Mouse–Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft ModelMonoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2020
- Antibody-drug conjugates- stability and formulationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2019
- Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and BiocompatibilityAntibodies, 2018
- Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocolJournal of Pharmaceutical and Biomedical Analysis, 2018
- Process Development and Structural Characterization of an Anti-Notch 3 Antibody–Drug ConjugateOrganic Process Research & Development, 2018
- Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular InteractionsMolecular Pharmaceutics, 2015
- Sequential learning in non-human primatesTrends in Cognitive Sciences, 2001
- [14] Cleavage at AsnGly bonds with hydroxylamine1977